An Efficacy Study Of Ortataxel In Recurrent Glioblastoma

NCT01989884 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mario Negri Institute for Pharmacological Research